Live Breaking News & Updates on Anti Cytomegalovirus Treatment Switching

Stay updated with breaking news from Anti cytomegalovirus treatment switching. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Takeda Pharmaceutical Company Limited: Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY (Maribavir) Had Reductions in Hospitalization Rates and Length of Hospital Stay

Data Include Exploratory Analysis Showing LIVTENCITY Treated Patients With Post-Transplant Cytomegalovirus (CMV) Infections/Disease Had Reductions in Hospitalizations (34.8%; p=0.021) and Length ....

United States , Salt Lake City , Barbara Alexander , Jun Saito , Clin Virol , Erin Marie Beals , Takeda Pharmaceuticals United States Inc , European Congress , International Report On Organ Donation , World Health Organization , Drug Administration , International Media , Exchange Commission , Takeda Pharmaceutical Company Limited , Springer International Publishing , Worldwide Network For Blood , Data Include Exploratory Analysis Showing , Patients With Post Transplant Cytomegalovirus , Disease Had Reductions , Hospital Stay , Those Treated With Conventional Antiviral , Hoc Analyses , Subgroup Showed Shorter Time , First Confirmed , Less Than , Lower Limit ,